androstane-3,17-diol has been researched along with Disease Models, Animal in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al Sweidi, S; Bourque, M; Caruso, D; Di Paolo, T; Melcangi, RC; Morissette, M | 1 |
Calza, L; Caruso, D; D'Intino, G; Garcia-Segura, LM; Giatti, S; Maschi, O; Melcangi, RC; Pesaresi, M | 1 |
Frye, CA; Rhodes, M; Ryan, A | 1 |
Frye, CA; Ryan, A | 1 |
Neumann, F; Rohr, HP; Schüring, B; Schweikert, HU; Senge, T; Tunn, UW | 1 |
Adams, JY; Alroy, J; Leav, I; Merk, FB; Schelling, KH | 2 |
Walsh, PC; Wilson, JD | 1 |
Loriaux, DL; Mellin, TN; Povar, ML; Rittmaster, RS; Uno, H | 1 |
9 other study(ies) available for androstane-3,17-diol and Disease Models, Animal
Article | Year |
---|---|
Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice.
Topics: Androstane-3,17-diol; Animals; Autoradiography; Brain; Carbon Radioisotopes; Cocaine; Dihydrotestosterone; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Progesterone; Testosterone; Vesicular Monoamine Transport Proteins | 2016 |
Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels.
Topics: 20-alpha-Dihydroprogesterone; Acute Disease; Androstane-3,17-diol; Animals; Brain; Chromatography, Liquid; Dihydrotestosterone; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Male; Mass Spectrometry; Multiple Sclerosis; Neurotransmitter Agents; Pregnanolone; Progesterone; Rats; Sex Characteristics; Testosterone | 2010 |
Antiseizure effects of 3alpha-androstanediol and/or 17beta-estradiol may involve actions at estrogen receptor beta.
Topics: Analysis of Variance; Androgen Antagonists; Androstane-3,17-diol; Animals; Anticonvulsants; Disease Models, Animal; Estradiol; Estrogen Receptor beta; Flutamide; Male; Pentylenetetrazole; Rats; Rats, Long-Evans; Reaction Time; Seizures | 2009 |
Antiseizure effects of 5*-androstane-3*,7beta-diol may be independent of actions at estrogen receptor beta.
Topics: Androstane-3,17-diol; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Estrogen Receptor beta; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pentylenetetrazole; Seizures | 2008 |
Morphometric analysis of prostates in castrated dogs after treatment with androstanediol, estradiol, and cyproterone acetate.
Topics: Androstane-3,17-diol; Androstanols; Animals; Castration; Cyproterone; Disease Models, Animal; Dogs; Estradiol; Male; Metaplasia; Prostate; Prostatic Hyperplasia; Stereoisomerism | 1981 |
Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 2001 |
Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Topics: Adenocarcinoma; Androstane-3,17-diol; Animals; Cell Division; Dihydrotestosterone; Disease Models, Animal; Dog Diseases; Dogs; Estradiol; Gonadal Steroid Hormones; Immunohistochemistry; Keratins; Ki-67 Antigen; Male; Orchiectomy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen | 2001 |
The induction of prostatic hypertrophy in the dog with androstanediol.
Topics: Androstane-3,17-diol; Androstanes; Animals; Castration; Dihydrotestosterone; Disease Models, Animal; Dogs; Estradiol; Estrone; Male; Prostatic Hyperplasia | 1976 |
The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque.
Topics: Alopecia; Androgen Antagonists; Androstane-3,17-diol; Animals; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Disease Models, Animal; Female; Hair; Macaca; Male; Oxidoreductases; Skin; Steroids, Heterocyclic; Testosterone | 1987 |